Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (71-80 of 268) with videos related to

Pageof 27
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cell-signaling targets for antitumour drug developmentV G Brunton, P Workman
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Nitroimidazoles as modifiers of nitrosourea pharmacokineticsF Y Lee, P Workman
The British Journal of Radiology|December 2, 2004
The role of functional and molecular imaging in cancer drug discovery and developmentB M Seddon, P Workman
Biochemical Pharmacology|January 22, 1992
Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cellsR J Riley, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1986
Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustardsF Y Lee, P Workman
British Journal of Cancer|January 1, 1985
Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNUF Y Lee, P Workman
Cancer Treatment Reports|August 1, 1977
A new high-glucuronidase mouse tumor curable by aniline mustard therapyJ A Double, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1993
Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerationsJ J Reilly, P Workman
European Journal of Cancer (Oxford, England : 1990)|March 11, 2000
Discovering novel chemotherapeutic drugs for the third millenniumM D Garrett, P Workman
Cancer Metastasis Reviews|June 1, 1993
The experimental development of bioreductive drugs and their role in cancer therapyP Workman, I J Stratford
Pageof 27

Showing results (71-80 of 268) with videos related to

Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cell-signaling targets for antitumour drug developmentV G Brunton, P Workman
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
Nitroimidazoles as modifiers of nitrosourea pharmacokineticsF Y Lee, P Workman
The British Journal of Radiology|December 2, 2004
The role of functional and molecular imaging in cancer drug discovery and developmentB M Seddon, P Workman
Biochemical Pharmacology|January 22, 1992
Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cellsR J Riley, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1986
Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustardsF Y Lee, P Workman
British Journal of Cancer|January 1, 1985
Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNUF Y Lee, P Workman
Cancer Treatment Reports|August 1, 1977
A new high-glucuronidase mouse tumor curable by aniline mustard therapyJ A Double, P Workman
Cancer Chemotherapy and Pharmacology|January 1, 1993
Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerationsJ J Reilly, P Workman
European Journal of Cancer (Oxford, England : 1990)|March 11, 2000
Discovering novel chemotherapeutic drugs for the third millenniumM D Garrett, P Workman
Cancer Metastasis Reviews|June 1, 1993
The experimental development of bioreductive drugs and their role in cancer therapyP Workman, I J Stratford
Pageof 27